Orthocell Limited

ASX (AUD): Orthocell Limited (OCC)

Last Price

1.42

Today's Change

+0.165 (13.14%)

Day's Change

1.28 - 1.46

Trading Volume

3,801,466

Overview

Market Cap

340 Million

Shares Outstanding

239 Million

Avg Volume

1,526,826

Avg Price (50 Days)

0.94

Avg Price (200 Days)

0.55

PE Ratio

-35.50

EPS

-0.04

Earnings Announcement

21-Feb-2025

Previous Close

1.25

Open

1.29

Day's Range

1.285 - 1.46

Year Range

0.35 - 1.66

Trading Volume

3,801,466

Price Change Highlight

1 Day Change

13.15%

5 Day Change

-3.40%

1 Month Change

49.47%

3 Month Change

175.73%

6 Month Change

305.71%

Ytd Change

-2.07%

1 Year Change

250.62%

3 Year Change

186.87%

5 Year Change

215.56%

10 Year Change

234.12%

Max Change

-71.02%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental application; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment